FogPharma and ARTBIO Announce Collaboration to Co-Develop Multiple Helicon™-Enabled Alpha-Particle Radioligand Therapies for the Treatment of Cancer Read More
Mirror-image ligand discovery enabled by single-shot fast-flow synthesis of D-proteins Nature Communications Read More